Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

06-Sep-2006

  • Project goes after high risk of prostate cancer and stroke in black men (Pittsburgh Post-Gazette)

    Undeterred by evening rush-hour traffic in Oakland, 11 middle-aged black men gathered around a conference table last week to learn more about ways to prevent prostate cancer and stroke.


  • Prevention: Daily Aspirin Use May Decrease Prostate Risks (New York Times)

    Taking aspirin every day may lower the risk for prostate enlargement, a new study has found.


  • GTx to continue prostate drug trials (Sharewatch)

    The monitoring board had reviewed the safety data of more than 2,700 patients enrolled in two Phase III clinical trials for Acapodene. The primary endpoint of the first, 1,400-patient study is the reduction of bone fractures in men with prostate cancer.


  • NFL star to promote prostate cancer awareness (The State)

    COLUMBIA Former NFL linebacker Levon Kirkland will be the guest speaker Thursday at All-Star Night, a free prostate cancer awareness dinner with sports-themed food, games and music.


  • GTx to Continue Prostate Drug Trials (AP via Yahoo! Finance)

    Biopharmaceutical company GTx Inc. said Tuesday it will continue two late-stage studies of its prostate cancer drug candidate after an independent drug safety monitoring board recommended GTx continue the research.


  • The key to surviving prostate cancer (Beaumont Enterprise)

    Mark M. Hancock/The Enterprise Donald H. Taft, right, and his wife, Stella, clean the kitchen of their home in Beaumont. Donald Taft is a prostate cancer survivor. He also is a parachutist and runner. He encourages men to have regular prostate screenings to catch the disease early.


  • Prostate Cancer (WGRZ-TV Buffalo)

    Buffalo Police Commissioner H. McCarthy Gipson has prostate cancer. 2 On Your Side spoke with a cancer expert at Roswell Park about the disease. Commissioner Gipson will begin radiation therapy in September.


  • GTx to Continue Prostate Drug Trials (KiplingerForecasts.com)

    (AP) MEMPHIS, Tenn. Biopharmaceutical company GTx Inc. said Tuesday it will continue two late-stage studies of its prostate cancer drug candidate after an independent drug safety monitoring board recommended GTx continue the research.


  • Prostate Cancer Awareness (KPLC)

    Prostate cancer is one of the leading causes of death among American men. But if detected early, it's curable with a number of different treatment options. KPLC's Laila Morcos talks with a local man who was diagnosed early and has been cancer free for five years.


  • Free prostate cancer screenings well attended (The Kentucky Standard)

    Although his father and grandfather both had been stricken with prostate cancer, Dr. Steve Henry, former Kentucky Lt. Governor, never gave much thought to his own chances of getting the disease. He was younger than the then recommended age 50 for annual screenings and had no symptoms.


  • Back to Prostate News Archive